Editor's Note In this survey of surgical, internal medicine, emergency medicine, and psychiatry residents by researchers from Florida Atlantic University’s Schmidt College of Medicine, Boca Rotan, residents reported having effective coping strategies during the early phase of the COVID-19 pandemic. A total of 59 residents completed the survey. Results showed…

Read More

Editor's Note The Food and Drug Administration on September 12 identified the recall by Medtronic Xomed of its NIM Contact Reinforced EMG Endotracheal Tube and NIM Standard Reinforced EMG Endotracheal Tube as Class I, the most serious. The recall was initiated after Medtronic Xomed received customer complaints about obstruction of…

Read More

Editor's Note The Joint Commission on September 7 released sentinel event data for the first 6 months of 2022. Of 832 events reviewed this year from January 1 to June 30, the top 10 most frequently reported were: Falls—199 Unintended retention of foreign objects—30 Suicides—26 Delays in treatment—25 Wrong surgery—19…

Read More

Editor's Note This study led by researchers at the Centers for Disease Control and Prevention (CDC) finds that COVID-19 vaccines are strongly associated with preventing serious illness. Analyzing data from 192,509 hospitalizations in 250 US hospitals: monthly COVID-19 associated hospitalization rates ranged from 3.5 to 17.7 times higher in unvaccinated…

Read More

Editor's Note The Food and Drug Administration (FDA) on September 8 issued a Safety Communication informing the public about reports of cancers, including squamous cell carcinomas and various lymphomas in the scar tissue that forms around breast implants. The various lymphomas are not the same as the lymphomas reported in…

Read More

Editor's Note The Food and Drug Administration (FDA) issued a safety communication alert on September 6 informing patients, caregivers, and healthcare providers that Philips Respironics (Philips) has recalled certain masks used with bilevel positive airway pressure (Bilevel PAP, BiPAP, or BPAP) machines and continuous positive airway pressure (CPAP) machines due…

Read More

Editor's Note The Food and Drug Administration (FDA) on August 31 identified the recall by Integra of its CereLink ICP Monitor as Class I, the most serious. The recall was initiated because the device may display incorrect values for a patient’s intracranial pressure (ICP) and display out-of-range pressure readings. If…

Read More

Editor's Note The Food and Drug Administration (FDA) on August 29 identified the recall by Hamilton Medical AG of its Hamilton-C6 Intensive Care Ventilator as Class I, the most serious. The recall was initiated because of potential water ingress between the indicator board and the ventilator’s main board that may…

Read More

Editor's Note This phase 3, double-blind, randomized, placebo-controlled study led by researchers at the University of Minnesota, Minneapolis, finds that none of three medications evaluated—metformin, ivermectin, or fluvoxamine—prevented the occurrence of a primary event—hypoxemia, an emergency department (ED) visit, hospitalization, or death—associated with COVID-19. Of 1,323 patients analyzed, a primary…

Read More

Editor's Note The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious. The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.…

Read More